Common concerns in managing bronchial asthma during the COVID-19 pandemic
The use of corticosteroids and nebulised bronchodilators in bronchial asthma (BA) is a major concern during the COVID-19 pandemic. Inhaled corticosteroid (ICS) is the recommended treatment for all levels of BA severity, while oral corticosteroid (OCS) is used in severe asthma and acute exacerbation...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
Ingenta
2020
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/30852/3/Common%20concerns.pdf http://ir.unimas.my/id/eprint/30852/ https://www.ingentaconnect.com/content/iuatld/ijtld/2020/00000024/00000007/art00022;jsessionid=dbmkm61qa88pb.x-ic-live-02# |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|